WuXi AppTec Co., Ltd. (2359.HK)
Chart Events
Performance Outlook
| Previous Close | 103.300 |
| Open | 103.800 |
| Bid | 100.500 x 0 |
| Ask | 101.300 x 0 |
| Day's Range | 100.200 - 104.300 |
| 52 Week Range | 57.900 - 137.700 |
| Volume | |
| Avg. Volume | 2,665,883 |
| Market Cap | 314.75B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.62 (1.00%) |
| Ex-Dividend Date | May 30, 2022 |
| 1y Target Est | 152.91 |
- PR Newswire
WuXi AppTec Named to the 2022 Dow Jones Sustainability World Index
WuXi AppTec, a leading global provider of R&D and manufacturing services that enables the global pharmaceutical and healthcare industry, today announced that it has been included in the 2022 Dow Jones Sustainability™ World Index (DJSI). This demonstrates the company's strong performance and commitment to Environmental, Social and Governance (ESG) initiatives.
- PR Newswire
WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan
WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services for the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, announced that it is a recipient of the 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan, a global research & consulting firm that helps customers accelerate growth. This marks the sixth consecut
- PR Newswire
WuXi AppTec Reports Record Year-to-Date Results in 2022, Third Quarter Revenue over RMB10 Billion
WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, is pleased to announce its financial results for the third quarter and nine months ended September 30, 2022 ("Reporting Period").
